FindTrial
Sign In

CONTROLLED STUDY OF FERRIC POLYMATOSATE VS FERRITINE IN THE TREATMENT OF FERROPENIC ANEMIA IN CHILDREN FROM 6 MONTHS TO 2 YEARS OLD.

CONTROLLED STUDY OF FERRIC POLYMATOSATE VS FERRITINE IN THE TREATMENT OF FERROPENIC ANEMIA IN CHILDREN FROM 6 MONTHS TO 2 YEARS OLD.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-068-02
Enrollment
Unknown
Registered
2002-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

polimaltosato ferrico Type of group
ferric polymaltosate will be administered 5 mg / K / day

Sponsors

VIFOR INTERNACIONAL,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. You must have the consent of the informed consent. 2. Have an age between 6 months and 2 years 3. Diagnosis of hlpochromic and microcytic anemia. 4. Hemoglobin S 8 and <10 g / dl. 5. Be able to attend the consultation according to the study schedule. 6. Be included in the percenfiles 10 - 90. Pondo-statural for age and sex according to the tables of the NCHS.

Exclusion criteria

Exclusion criteria: 1. History of intolerance to iron salts. 2. History of chronic anemia resistant to treatment. 3. Acute pathologies (e.g., acute infections) or chronic diseases (e.g. intestinal malabsorption syndrome) that can modify the blood values.

Design outcomes

Primary

MeasureTime frame
Outcome name:not contemplated Measure:not contemplated Timepoints:not contemplated—

Secondary

MeasureTime frame
Outcome name:not contemplated Measure:not contemplated Timepoints:not contemplated—

Countries

Peru, Venezuela

Outcome results

None listed

Source: REPEC (via WHO ICTRP)